Search results for "Kinin"

showing 10 items of 194 documents

Gastrin-cholecystokinin-like immunoreactivity in the central nervous system of the milkweed bug, Spilostethus pandurus. Ultrastructural aspects of th…

1995

Summary All the ganglia belonging to the central nervous system of adults of the milkweed bug Spilostethus pandurus (Hemiptera) were screened immunohistochemically for vertebrate gastrin-cholecystokinin (CCK-8(s))-like peptides. Several large reactive perikarya are present in the median part of the protocerebrum, their processes extending to the dorsal ‘aorta’. These cell bodies are also paraldehyde fuchsin-positive, ie they are A-type cells. In the lateral part of the protocerebrum, in the deutocerebrum and tritocerebrum, and in the suboesophageal, prothoracic and abdominal ganglia, a few immunoreactive cell bodies send axonal processes into their respective neuropiles. The A-type cells re…

Pathologymedicine.medical_specialtybiologyImmunocytochemistryCentral nervous systemNeuropeptideCell BiologyGeneral MedicineAnatomyImmunogold labellingbiology.organism_classificationmedicine.anatomical_structureSpilostethus pandurusmedicineUltrastructureGastrinCholecystokininBiology of the Cell
researchProduct

Bradykinin modulates spontaneous nerve growth factor production and stretch-induced ATP release in human urothelium

2013

The urothelium plays a crucial role in integrating urinary bladder sensory outputs, responding to mechanical stress and chemical stimulation by producing several diffusible mediators, including ATP and, possibly, neurotrophin nerve growth factor (NGF). Such urothelial mediators activate underlying afferents and thus may contribute to normal bladder sensation and possibly to the development of bladder overactivity. The muscle-contracting and pain-inducing peptide bradykinin is produced in various inflammatory and non-inflammatory pathologies associated with bladder overactivity, but the effect of bradykinin on human urothelial function has not yet been characterized. The human urothelial cel…

Pharmacology0303 health sciencesmedicine.medical_specialtyUrothelial CellBradykinin B2 Receptor AntagonistsReceptor expression030232 urology & nephrologyBradykininNerve growth factor productionBiology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNerve growth factorEndocrinologychemistryIcatibantInternal medicinemedicineBradykinin receptor030304 developmental biologyPharmacological Research
researchProduct

Role of NK1 and NK2 receptors in mouse gastric mechanical activity

2006

The aim of the present study was to examine the role of NK1 and NK2 receptors in the control of mechanical activity of mouse stomach. In this view, the motor effects induced by NK1 and NK2 receptor agonists and antagonists were analyzed, measuring motility as intraluminal pressure changes in mouse-isolated stomach preparations. In parallel, immunohistochemical studies were performed to identify the location of NK1 and NK2 receptors on myenteric neurons and smooth muscle cells. Substance P (SP) induced biphasic effects: a contraction followed by relaxation; neurokinin A (NKA) and [β-Ala8]-NKA(4−10), selective agonist of NK2 receptors, evoked concentration-dependent contractions, whereas [Sar…

PharmacologyAgonistmedicine.medical_specialtymedicine.drug_classNeuropeptideSubstance PBiologyInhibitory postsynaptic potentialchemistry.chemical_compoundEndocrinologychemistryInternal medicineTetrodotoxinmedicineNK1 receptor antagonistNeurokinin AReceptorBritish Journal of Pharmacology
researchProduct

Changes of the renin-angiotensin and of the kallikrein-kinin system after administration of saline, christalloid and colloid solution in the rat. Eff…

1988

PharmacologyBlood VolumeCaptoprilChemistrymedicine.medical_treatmentCaptoprilKininsKininPharmacologySodium ChlorideRatsRenin-Angiotensin SystemSolutionsColloidGlucoseFurosemideRenin–angiotensin systemmedicineAnimalsKallikreinsColloidsSalinemedicine.drugPharmacological research communications
researchProduct

Isolation of endothelin A receptor from bovine lungs.

1995

We isolated endothelin receptor A (ET A ) from bovine lungs in a single-step purification procedure using antibodies raised against synthetic peptides that correspond to extra- and intracellular domains of the rat bradykinin receptor. Two receptor species of 55 and 35 kDa were isolated and subjected to N-terminal microsequencing. The difference between the observed and expected molecular weight species suggests that bovine ET A receptor is glycosylated.

PharmacologyGlycosylationReceptors EndothelinBiologyIn vitroRatsMolecular Weightchemistry.chemical_compoundBiochemistryAffinity chromatographychemistrybiology.proteinAnimalsCattleRabbitsAntibodyBradykinin receptorCardiology and Cardiovascular MedicineEndothelin receptorReceptorLungIntracellularJournal of cardiovascular pharmacology
researchProduct

Anti-Idiotypic Antibodies Against the Kinin Receptor

1992

Three sets of monoclonal antibodies against bradykinin (MBK1, MBK2, and MBK3) were generated by somatic cell fusion, characterized by their peptide specificity, and compared with the known ligand specificity of the kinin receptor subtypes. By these criteria, the paratope of MBK3 resembled the B 2 receptor binding site, whereas MBK1 shared principal binding characteristics with the B 1 receptor. Anti-idiotypic antibodies against MBK1, MBK2, and MBK3 were raised in rabbit and sheep

PharmacologyIdiotypemedicine.drug_classKininBiologyLigand (biochemistry)Monoclonal antibodyMolecular biologymedicineEnzyme-linked receptorParatopeBradykinin receptorCardiology and Cardiovascular MedicineReceptorJournal of Cardiovascular Pharmacology
researchProduct

ACE inhibitor potentiation of bradykinin-induced venoconstriction

1997

1. Angiotensin-converting enzyme (ACE) inhibitors exert their cardiovascular effects not only by preventing the formation of angiotensin II (AII), but also by promoting the accumulation of bradykinin in or at the vessel wall. In addition, certain ACE inhibitors have been shown to augment the vasodilator response to bradykinin, presumably by an interaction at the level of the B2 receptor. We have investigated whether this is a specific effect of the ACE inhibitor class of compounds in isolated endothelium-denuded segments of the rabbit jugular vein where bradykinin elicits a constrictor response which is exclusively mediated by activation of the B2 receptor. 2. Moexiprilat and ramiprilat (< …

PharmacologyRamiprilmedicine.medical_specialtybiologyEnalaprilatBradykininAngiotensin-converting enzymeCaptoprilchemistry.chemical_compoundEndocrinologychemistryInternal medicineACE inhibitorcardiovascular systemmedicinebiology.proteinBradykinin receptorRamiprilatmedicine.drugBritish Journal of Pharmacology
researchProduct

Award ceremony of the E.K. Frey-E. Werle Foundation of the Henning L. Voigt family.

1997

Pharmacologymedia_common.quotation_subjectFoundation (engineering)Awards and PrizesArt historyHistorical ArticleBiographyArtKininsHistory 20th CenturyCeremonySouth AfricaPortraitGermanymedia_commonImmunopharmacology
researchProduct

Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors

2001

The effects of anandamide on [3H]-acetylcholine release and muscle contraction were studied on the myenteric plexus-longitudinal muscle preparation of the guinea-pig ileum preincubated with [3H]-choline. Anandamide increased both basal [3H]-acetylcholine release (pEC50 6.3) and muscle tone (pEC50 6.3). The concentration-response curves for anandamide were shifted to the right by 1 μM capsazepine (pKB 7.5 and 7.6), and by the combined blockade of NK1 and NK3 tachykinin receptors with the antagonists CP99994 plus SR142801 (each 0.1 μM). The CB1 and CB2 receptor antagonists, SR141716A (1 μM) and SR144528 (30 nM), did not modify the facilitatory effects of anandamide. Anandamide inhibited the e…

Pharmacologymedicine.medical_specialtyCannabinoid receptormedicine.medical_treatmentTRPV1AnandamideMuscarinic agonistchemistry.chemical_compoundEndocrinologychemistryInternal medicinemedicineCannabinoidCapsazepineTachykinin receptorAcetylcholinemedicine.drugBritish Journal of Pharmacology
researchProduct

Tachykinergic neurotransmission is enhanced in duodenum from dystrophic (mdx ) mice

2005

1 Duodenal longitudinal muscle of mdx mice, an animal model for Duchenne muscular dystrophy, showed a decrease in the electrically evoked nonadrenergic, noncholinergic (NANC) inhibitory responses associated with a reduction of the participation of nitric oxide (NO). In this study, we investigated whether the impairment of NO could also lead to alterations in the NANC excitatory transmission. 2 Nerve-evoked responses consisted of an inhibitory phase followed, at the end of stimulation, by an excitatory response characterised by an increase in amplitude of the spontaneous contractions. In mdx mice, the amplitude of the nerve-evoked contractions was significantly higher than in normals. 3 N(om…

Pharmacologymedicine.medical_specialtySubstance PStimulationBiologyNeurotransmissionApaminchemistry.chemical_compoundEndocrinologychemistryInternal medicineExcitatory postsynaptic potentialmedicineSodium nitroprussideNeurokinin ASoluble guanylyl cyclasemedicine.drugBritish Journal of Pharmacology
researchProduct